Georgia's Online Cancer Information Center

Hereditary Breast and Ovarian Cancer: Risk Assessment in Minority Women and Provider Knowledge Gaps

6/29/2016, Nancy M Paris, et al

Nancy M Paris, MS, FACHE,a Sheryl GA Gabram-Mendola, MD, MBA, FACS,b Alice S Kerber, MN, APRN, ACNS-BC, AOCN, APNG,a Jean O?Connor, JD, MPH, DrPH,cBarbara E Crane, MN, APRN,c Monique L Martin, MPH, CHES,d Lucy Brannon Traxler, MD,e Roland Matthews, MD,f Christopher Parker MBBS, MPH,g Rachel Webster, MMSc, CGC,h Elizabeth Schmitt, MMSc, CGC,i Dana Meaney-Delman, MD, MPH,j Navya Nair, MD, MPH,k Victoria L Green, MD, JD, MBA,l and Cecelia A Bellcross, PhD, MS, CGCm

Background The Georgia Breast Cancer Genomics Project identified minority and underserved women at high risk for hereditary breast and ovarian cancer based on family history. Education, web-based screening, genetic counseling, and testing were provided in public health and primary care settings in accordance with evidence-based recommendations and guidelines.

Objectives To assess risk of hereditary breast and ovarian cancer (HBOC) among minority and underserved women, provide genetic services according to evidence-based guidelines, and evaluate provider knowledge of HBOC.

Methods The Georgia Department of Public Health established this project through a cooperative agreement with the Centers for Disease Control and Prevention. HBOC screening and genetic services were provided in 13 public health centers and federally qualified health centers. Staff received training on genetics and risk assessment using the Breast Cancer Genetics Referral Screening Tool (B-RST). Providers and medical residents were surveyed on their knowledge of HBOC. Young women with breast cancer were surveyed on receipt of genetic services.

Results More than 5,400 women were successfully screened; 79% identified as racial/ethnic minorities. 5% of women screened positive on the B-RST, which is consistent with HBOC prevalence; 79% agreed to follow up. 23% met criteria for increased risk of BRCA 1/2 mutation and received genetic counseling and testing. Surveys revealed profound gaps in knowledge among physicians and medical residents and lack of delivery of evidence-based genetic services to survivors.

Conclusions The genomics project demonstrated the efficacy of population-based screening to identify high-risk women before they receive a diagnosis of cancer. A high percentage of women who screened positive also completed genetic counseling and testing. Access to the benefits of HBOC management to prevent cancer and decrease mortality among minority and underserved women depends on improvements in knowledge of genetics and evidence-based practice by providers.

Funding/sponsorship This project was funded through a cooperative agreement from the Centers for Disease Control and Prevention to the Georgia Department of Public Health from 2011-2014.

For more information or to read the paper, click here.

Media, News & Events

Greetings of gratitude from our president and CEO

Lynn gives a message of thanks and a glimpse into what's to come in 2022.

11/18/2021

Cancer Center opens in Braselton

“This new collaborative space puts our patients’ needs front and center by providing a more cohesive environment with access to both medical oncology/hematology and radiation oncology services within steps of each other,” says Charles Nash III, MD, FACP, medical director of NGMC’s Cancer Services and medical oncologist with Longstreet Clinic (and Georgia CORE Board member).

6/29/2021

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.